【石四药集团(02005.HK):SYN045片已取得国药监局新增三种不同规格(10mg、25mg及50mg)的一期临床试验许可】石四药集团(02005.HK)发布公告,该集团的化学药品1类新药SYN045片已取得中国国家药品监督管理局新增三种不同规格(10mg、25mg及50mg)的一期临床试验许可,可以满足临床试验多样化需求,针对不同年龄段患者实现剂量梯度给药,进一步优化精准给药方案,提升SYN045片的临床应用价值。

金融界
03 Apr
石四药集团(02005.HK)发布公告,该集团的化学药品1类新药SYN045片已取得中国国家药品监督管理局新增三种不同规格(10mg、25mg及50mg)的一期临床试验许可,可以满足临床试验多样化需求,针对不同年龄段患者实现剂量梯度给药,进一步优化精准给药方案,提升SYN045片的临床应用价值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10